| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 6.46▲ | 6.47▼ | 6.49▼ | 5.83▲ | 4.97▲ |
| MA10 | 6.46▲ | 6.47▼ | 6.42▲ | 5.46▲ | 4.93▲ |
| MA20 | 6.46▲ | 6.41▲ | 6.14▲ | 4.89▲ | 5.32▲ |
| MA50 | 6.47▲ | 5.99▲ | 5.66▲ | 4.93▲ | 6.11▲ |
| MA100 | 6.42▲ | 5.64▲ | 5.14▲ | 5.37▲ | 8.57▼ |
| MA200 | 6.19▲ | 5.07▲ | 4.85▲ | 5.86▲ | 9.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.025▼ | 0.002▲ | 0.208▲ | 0.134▲ |
| RSI | 53.171▲ | 64.593▲ | 70.653▲ | 73.410▲ | 59.150▲ |
| STOCH | 49.444 | 80.068▲ | 83.064▲ | 81.192▲ | 36.997 |
| WILL %R | -33.333 | -18.841▲ | -14.062▲ | -3.673▲ | -3.557▲ |
| CCI | 122.581▲ | 49.749 | 71.029 | 151.395▲ | 139.240▲ |
| BBANDS | $BCRX Bollinger Bands Expanding | Set Alert |
|
Wednesday, May 15, 2024 08:00 AM
Anthony Doyle, Chief Financial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 36,300 shares of the company on May 14, 2024.
|
|
Wednesday, May 15, 2024 08:00 AM
Steven Galson, a Director at BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 21,940 shares of the company, as reported in a recent SEC Filing.
|
|
Wednesday, May 15, 2024 08:00 AM
Charles Gayer, Chief Commercial Officer of BioCryst Pharmaceuticals Inc (NASDAQ:BCRX), purchased 30,000 shares of the company on May 13, 2024.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/05/24 | 6.41 | 6.535 | 6.19 | 6.47 | 5,083,884 |
| 15/05/24 | 5.93 | 6.56 | 5.90 | 6.36 | 10,487,304 |
| 14/05/24 | 5.72 | 6.00 | 5.35 | 5.36 | 2,730,629 |
| 13/05/24 | 5.42 | 5.69 | 5.345 | 5.64 | 3,112,404 |
| 10/05/24 | 5.38 | 5.775 | 5.23 | 5.32 | 3,502,122 |
| 09/05/24 | 5.14 | 5.35 | 5.06 | 5.34 | 3,357,148 |
| 08/05/24 | 5.18 | 5.42 | 5.04 | 5.10 | 3,789,588 |
| 07/05/24 | 5.39 | 5.70 | 5.225 | 5.26 | 6,215,852 |
| 06/05/24 | 5.00 | 5.47 | 4.75 | 5.27 | 8,898,733 |
| 03/05/24 | 4.59 | 4.67 | 4.42 | 4.45 | 2,737,172 |
|
|
||||
|
|
||||
|
|